Loading
Market closed, from the scannerPrice and score as of 5:25 PM ET
AKTS
Aktis Oncology, Inc.
Weak
$21.88-4.29%Biotech · $1B
Quality Score
1
Weak
Traits firing
1 of 13
Transition
In its industry
#177
of 253 stocks
From 52-week high
-36.0%
Below the 200-day
A slice of the scanner. Members see all 14 checks and every score line on AKTS, every stock ranked, the chart, and optional alerts.Start free trial →
Reports in about 4 weeksWhy it scores 11 of 13 traits firing9 insider filingsRanked against 253 in its industry
Signed in
Every check, every score, and a push when it changes.
What a member sees on AKTS and on every one of the 2,957 stocks. The picture is AMD's page.
- All 14 checks and every line of the Quality Score, on AKTS and on every other stock
- Every stock ranked by score in every sector and industry, with the filters that find the ones that match today
- The chart, with moving averages, RSI, MACD, and every earnings and insider mark on it
- Every filing on the stock, sorted, filtered, and downloadable, not the newest eight
- Optional alerts on AKTS: a filing, a price, a score, an earnings date, 21 rules in all, off until you set one
- A watchlist, saved scans, and a trade plan you can edit
Start 7-day free trial7 days free. No card.
Earnings
When does AKTS report, and what happens after?
An estimate; the company has not confirmed a date. When it does, the 8-K sets it.
Reports in about 4 weeksaround Oct 20, 2026, after close, estimated.
Over its last 3 reports it gapped +1.7% on average and closed +7.0%, finishing higher 100% of the time.
+8.2%+8.0%+4.8%
Mar 30May 11Aug 13
| Reported | When | Gap | Reaction | 5 sessions |
|---|
Quality Score
Why AKTS scores 1
The two largest lines, with the reason behind each. Every line adds up to the badge; members see all of them.
1Quality:
WeakWeakTransition, 1 of 13 traits firing
WeakWeakTransition, 1 of 13 traits firing
Average is 5, Good 10, Strong 14, Exceptional 18.
- +1
Momentum traits
1 of AKTS's 13 conditions is firing
One check from each of the four groups is shown, a firing one when the group has one. Volume expansion and volume dry-up cannot both be true, so 13 is the most any stock can score.
Trend0 on, 1 of 5 shown
MA FAN21 EMAW.EMAHH/HL52W HI
The moving averages stack in order. Price holds above a rising 21-day line. The weekly chart agrees, and the stock sits near its 52-week high.
Volume1 on, 1 of 3 shown
VOLVDUU/D VOL
Heavy volume when the stock runs, and quiet volume while it rests. More shares change hands on up days than on down days.
Tight range0 on, 1 of 3 shown
ATR SQZSQUEEZENR7
The daily trading range gets tight against the stock's own history. Quiet ranges do not stay quiet forever.
Insider filings
Who is buying and selling AKTS inside the company
Open-market Form 4 filings from the SEC, newest filing first. Grants, option exercises, and tax withholding are left out.
3 insiders sold $3M across 9 filings in the last 6 months. No open-market buys on record.
- SellKen Herrmann$86KDirectorat $24.56 on Jul 20, filed Jul 21SellKen HerrmannDirector$86Kat $24.56 on Jul 20, filed Jul 21
- SellKen Herrmann$33KDirectorat $24.56 on Jul 20, filed Jul 21Sell
Optional alerts
Have AKTS tell you.
Alerts are off until you set one. This is the push AKTS's own filing would have sent.
BreakawayJul 21Ken Herrmann sold AKTS$86K at $24.56, filed Jul 21
Your rule: an insider buys AKTS.This is what the push looks like.
Government trade disclosedInsider buying filedEarnings within a few daysNews catalystNew 52-week highA pre-market or after-hours moveVolume above a level you pickSqueeze setup appearsMACD bullish crossA price you pick
21 rules in all, on one stock or on every stock, by push or by email.
Its industry
How AKTS ranks in Biotech
AKTS is 177 of 253 by Quality Score. The three highest are ranked; the rest are listed by name, with their scores for members.
See this on all 2,957 stocks.
Live, with no delay. Alerts are optional, and a filing is one of 21 rules you can set.
- Every filing on the stock, not the newest eight
- Sort and filter by side, role, size, party, or chamber
- Six months of Congress trades, three months of insider buys and earnings reactions
- Download any list you have filtered as a spreadsheet
- A watchlist, saved scans, the market map, and every sector and industry ranked
- Optional alerts by push or email, on your phone or your desk
Start 7-day free trial
7 days free. No card. Cancel in two clicks.
Questions
Straight Answers
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government trades come from the public STOCK Act and Office of Government Ethics filings. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week traits and the setup odds rest on real history. Options flow is not part of the product.
How often does it update?
The scan rebuilds every 15 seconds while the market is open, and every five minutes when it is closed. An open scanner tab picks up each rebuild without a refresh. Prices, scores, the ranking and the market line update in place. Nothing flickers when nothing has changed. The whole-market movers refresh every 15 seconds too. News sweeps the whole list every few minutes. Congress filings are checked every hour, insider filings every three hours and earnings every six, and a company expected to report tonight or this morning is checked every five minutes until its filing lands. Short interest, holders, and profits refresh on their own schedules. The ticker page states each schedule beside the figure.
What does it cost?
A screening tool for momentum traders. It ranks technical and news conditions. It is not investment advice, and nothing here is a recommendation to buy or sell any security. The price, the score, the traits, and the industry rank on this page are delayed at least 15 minutes. Filings are shown as filed, because a disclosure is already days or weeks old when it becomes public. Earnings dates and past reactions are settled sessions.